[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

PH25733A - 5-aryl-3h-1,2,4-triazol-3-ones, their use in the treatment of neurogenerative disorders - Google Patents

5-aryl-3h-1,2,4-triazol-3-ones, their use in the treatment of neurogenerative disorders

Info

Publication number
PH25733A
PH25733A PH36230A PH36230A PH25733A PH 25733 A PH25733 A PH 25733A PH 36230 A PH36230 A PH 36230A PH 36230 A PH36230 A PH 36230A PH 25733 A PH25733 A PH 25733A
Authority
PH
Philippines
Prior art keywords
triazol
aryl
ones
treatment
neurogenerative disorders
Prior art date
Application number
PH36230A
Inventor
Francis P Miller
Stephen Sorensen
John M Kane
Original Assignee
Merrel Dow Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrel Dow Pharmaceuticals filed Critical Merrel Dow Pharmaceuticals
Publication of PH25733A publication Critical patent/PH25733A/en

Links

PH36230A 1987-10-16 1987-12-15 5-aryl-3h-1,2,4-triazol-3-ones, their use in the treatment of neurogenerative disorders PH25733A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10700187A 1987-10-16 1987-10-16

Publications (1)

Publication Number Publication Date
PH25733A true PH25733A (en) 1991-10-18

Family

ID=22314340

Family Applications (1)

Application Number Title Priority Date Filing Date
PH36230A PH25733A (en) 1987-10-16 1987-12-15 5-aryl-3h-1,2,4-triazol-3-ones, their use in the treatment of neurogenerative disorders

Country Status (2)

Country Link
PH (1) PH25733A (en)
ZA (1) ZA879420B (en)

Also Published As

Publication number Publication date
ZA879420B (en) 1988-07-27

Similar Documents

Publication Publication Date Title
GB2207055B (en) Apparatus for use in the treatment of spinal disorders
EP0205579A4 (en) Methods and compositions useful in the diagnosis and treatment of autoimmune diseases.
NZ227332A (en) Ribozymes, production and use
ZA887889B (en) Process for the manufacture of 1,1,1-trifluorodichloroethylene and 1,1,1,2-tetrafluorochloroethylene
EP0243968A3 (en) Diacetylrhein salts and their therapeutical use in the treatment of arthritis
HK36693A (en) Use of ketone derivatives in the treatment of cognitive disorders
EP0432856A3 (en) Use of rolipram in the treatment of dementia
AU8240687A (en) Preparation suitable for use in the treatment of enteric disorders
JPS6440456A (en) Substituted n-benzoyl-n'-2,5-dihalo-4- perfluoroalkoxyphenylurea, manufacture and use for vermicide
ZA913497B (en) Azabenzimidazoles in the treatment of asthma,arthritis and related diseases
EP0437026A3 (en) Use of tandospirone in the treatment of depression
GB2177398B (en) 5,6-epoxy-7-oxabicycloheptane substituted ethers useful in the treatment of thrombotic disease
GB2203645B (en) Improvements in the treatment of hair
ZA935154B (en) Use of 1,2,5-oxadiazole-2-oxides for the treatment of erectile dysfunctions
ZA842223B (en) Method for the preparation of 1,8-dihydroxy-10-acyl-9-anthrones,especially for use in the treatment of psoriasis
ZA849576B (en) 1,7-diphenyl-3-methyllaza-7-cyano-8-methylnonane for use in the treatment of diseases
ZA908490B (en) Use of arylalkylamides in the treatment of neurodegenerative diseases
EP0271127A3 (en) Use of guaifenesin in the treatment of urologic disorders
GB8715914D0 (en) Treatment of cerabral disorders
EP0215200A3 (en) Use of sulfanilamido quinoxalines in the treatment of neoplastic diseases
ZA887364B (en) Ovulation treatment
PH25733A (en) 5-aryl-3h-1,2,4-triazol-3-ones, their use in the treatment of neurogenerative disorders
ZA889251B (en) 8,9-annelated-beta-carbolines and 8,9-annelated-3,4-dihydro-beta-carbolines
AU4096789A (en) The use of lactam derivatives in the treatment of cognitive disorders
JPS6422876A (en) 8 alpha-acylaminoergoline, manufacture and medicine